Tegument proteins play critical roles in herpesvirus morphogenesis. ORF45 is a conserved tegument protein of gammaherpesviruses; however, its role in virion morphogenesis is largely unknown. In this work, we determined the ultrastructural localization of murine gammaherpesvirus 68 (MHV-68) ORF45 and found that this protein was incorporated into virions around the site of host-derived vesicles. Notably, the absence of ORF45 inhibited nucleocapsid egress and blocked cytoplasmic virion maturation, demonstrating that ORF45 is essential for MHV-68 virion morphogenesis.
A s a unique structure of herpesviruses, tegument functions in multiple aspects of the viral life cycle, including modulation of the host cellular environment and initiation of viral gene transcription at the immediate-early phase of virus infection, transport of nucleocapsids to the nuclear pore, and virion morphogenesis and egress (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . Virion morphogenesis is a complicated event that takes place in the late phase of the herpesvirus lytic life cycle. After acquisition of viral genomes in the nucleus, nucleocapsids bud at the inner nuclear membrane to form primary virions in the perinuclear space, followed by deenvelopment at the outer nuclear membrane, releasing capsids into the cytoplasm. Capsids then undergo tegumentation and reenvelopment to obtain tegument proteins and envelope glycoproteins (11, 12, 13) . Finally, mature virions are released from the cell.
ORF45 is a virion-associated protein that is conserved in gammaherpesviruses but has no homologue in alpha-or betaherpesviruses. The ORF45 homologues in Kaposi's sarcoma-associated herpesvirus (KSHV), murine gammaherpesvirus 68 (MHV-68), Epstein-Barr virus (EBV), and rhesus rhadinovirus (RRV) are 407 amino acids (aa), 206 aa, 217 aa, and 353 aa, respectively (14, 15) . The homology mainly lies in the C-terminal region of the protein. Among these homologues, KSHV ORF45 is the best studied. It is virion associated (16, 17) and is a multifunctional protein. It interacts with interferon regulatory factor 7 and inhibits virus-induced interferon production, leading to viral immune evasion (2, 18) . Characterization of a KSHV ORF45-null bacterial artificial chromosome (BAC) showed that although ORF45 is not essential for KSHV lytic replication, it plays roles in both early and late stages of viral infection (19) . Indeed, ORF45 was shown to interact with kinesin-2 to mediate the transport of viral particles along microtubules (4) . ORF45 also interacts with another tegument protein, ORF33, and plays a crucial role in efficient production of KSHV viral particles (15) . Most recently, ORF45 was shown to mediate association of KSHV particles with internal lipid rafts for viral assembly and egress (20) .
MHV-68 ORF45 has also been identified as a virion-associated protein (21, 22, 23) . Biochemical analysis demonstrated that ORF45 is a true tegument protein that is packaged into virions (23) . By construction and analysis of an ORF45-null MHV-68 mutant using a BAC system, Jia et al. demonstrated that the ORF45-null MHV-68 BAC is incapable of virion production, indicating that newly synthesized ORF45 is essential for MHV-68 lytic replication (3). However, this defect can be rescued in trans by ORF45 fused to green fluorescent protein (GFP) to generate an ORF45-null mutant virus, although the packaging efficiency of GFP-ORF45 protein was significantly lower in the ORF45-null mutant than in the wild-type (WT) ORF45 protein in WT virions (3) . Viral gene expression and DNA replication were blocked during de novo infection of the mutant virus, suggesting that the virion-associated GFP-ORF45 protein plays an important role in viral gene expression. Kinetically, ORF45 is a highly expressed earlylate gene (24, 25) . Thus, newly synthesized ORF45 is not expected to regulate viral immediate-early or early gene expression in the same infected cell. However, newly synthesized ORF45 is packaged into virions as tegument protein, and the virion-associated ORF45 protein can then be delivered into new cells during the next round of de novo infection and may modulate viral gene expression in the new cells. Because virion morphogenesis takes place following viral DNA replication and late gene expression, the role of newly synthesized ORF45, if any, in virion morphogenesis could not be studied by such an approach. Therefore, we decided to directly address the role of newly synthesized ORF45 in viral lytic replication under BAC transfection conditions and within "single-round" viral replication, so that the effect of virionassociated ORF45 could not confound our data analysis.
We first examined the subcellular localization of MHV-68 ORF45 during virus infection, as the function of a protein is inevitably linked to its localization within the cell. Structured illumination microscopy (SIM) uses a grid to create several interference patterns on the sample for each z plane and captures multiple cross sections of the specimen, producing three-dimensional images with a high resolution (26) . By taking advantage of this technology, we found that ORF45 was localized in both the nucleus and the cytoplasmic area (Fig. 1A) . Such distribution is consistent with the subcellular distribution of its homologue in KSHV (27, 28) .
We next performed an immunogold labeling assay to examine the ultrastructural localization of ORF45 and its association with infected with MHV-68 at a multiplicity of infection (MOI) of 3. At 24 h postinfection, cells were fixed and subjected to an indirect immunofluorescence assay using a rabbit polyclonal anti-ORF45 antibody (Ab) or rabbit IgG as a negative control and observed with a three-dimensional structured illumination microscope (Delta Vision OMX). The anti-ORF45 antibody and rabbit IgG were detected using an Alexa Fluor 488-conjugated secondary antibody (green channel). Nuclei were stained with DAPI (4=,6-diamidino-2-phenylindole) (blue channel). (B) BHK-21 cells were infected with WT MHV-68 at an MOI of 5 and analyzed 11 h later by immunoelectron microscopy with the anti-ORF45 antibody (B1 to B7 and B10) or rabbit IgG as a negative control (B8 and B9), followed by a secondary antibody conjugated with 5-nm gold particles. Gold particles were found dispersed in the nucleus (Nu) around intranuclear capsids or with low occupancy on intranuclear capsids (B1, with black arrowheads indicating intranuclear capsids labeled with gold particles), abundantly in the nuclear inclusion body (B2) and the nuclear membrane area (Nm) (B3), with low occupancy on primary virions (B4, with white arrow indicating a primary virion labeled with a gold particle), abundantly in the tegument deposit (B5, B6, and B10), on capsids undergoing tegumentation (B10, black arrowheads) and secondary envelopment in the cytoplasm (Cyto) (B6 and B10, white arrows), and on mature virions in the cytoplasm (B7). Few gold particles were found in samples treated with rabbit IgG (B8 and B9).
virions. BHK-21 cells were infected with MHV-68, fixed, embedded, and sectioned. The sections were immunolabeled with either a rabbit anti-ORF45 polyclonal antibody or rabbit IgG as a negative control, followed by a secondary antibody conjugated with 5-nm gold particles. As shown in Fig. 1B , in the nucleus, dispersed distribution of gold particles around intranuclear capsids (Fig. 1B,  B1 ), as well as accumulation of gold particles in inclusion bodies formed during virion assembly and egress (29) (Fig. 1B, B2 ) and around nuclear membrane areas (Fig. 1B, B3) , were observed. Despite abundant distribution of gold particles in the nucleus, labeling of intranuclear capsids (Fig. 1B, B1 , black arrowhead) or primary virions in the perinuclear space (Fig. 1B, B4 , white arrow) occurred only infrequently. In the cytoplasm, gold particles accumulated in electron-dense areas, designated tegument deposits (29) , around host-derived vesicles (Fig. 1B, B5 , B6, and B10), consistent with the cytoplasmic fluorescent signals revealed in the SIM images (Fig. 1A) . Furthermore, gold particles were detected on mature virions (Fig. 1B, B7 ). In the negative-control sample treated with rabbit IgG, very few gold particles were detected in either the nucleus or the cytoplasm (Fig. 1B, B8 and B9), indicating the specificity of immunogold staining. Notably, tegument deposits were very frequently observed and emerged in almost all infected cells with an ongoing virion morphogenesis process. In addition, accumulation of capsids, tegument deposits, host-derived vesicles, and virions undergoing secondary envelopment formed representative structures in the cytoplasmic area (Fig. 1B,  B5 , B6, and B10).
We further quantified labeling of capsids outside deposits (n ϭ 134) and virions undergoing secondary envelopment at vesicles surrounded or semisurrounded by tegument deposits (n ϭ 51). Most capsids (76.1%) (Fig. 1B, B6 , and B10, black arrows, and images not shown) did not contain ORF45, but a portion of labeled capsids (23.9%) (Fig. 1B, B10 , black arrowheads, and images not shown) emerged around the tegument deposit, suggesting that ORF45 was likely to be incorporated into virions at the tegument deposit area. Most virions (88.2%) (Fig. 1B, B6 and B10, white arrows, and data not shown) contained ORF45, again strongly indicating that ORF45 was incorporated into virions at the tegument deposit area. The portion of virions (11.8%; data not shown) which was not labeled might be due to several reasons. For example, depending on the relative location of ORF45 protein within the embedded sample block, it may be difficult for the anti-ORF45 antibody to gain access to ORF45 and/or for gold particles to penetrate the medium used to embed samples for electron microscopy analysis. Collectively, these images revealed not only the distribution of ORF45 within the cell but also the sites where ORF45 was loaded into virions, suggesting multiple roles for the protein during virion assembly and egress.
To determine the function of newly synthesized ORF45 in virus lytic replication, we generated an ORF45-null (45S) BAC by inserting triple-stop codons and a BglII site between nucleotide (nt) 64156 and nt 64157 on the viral genome (116 nt downstream of the translation initiation codon for ORF45) using a two-step lambda Red recombination method, according to a previous report (3) . A revertant of the ORF45-null mutant (45S.R) was also generated by deleting the BglII site and triple-stop codons from the 45S BAC using the same method. Restriction enzyme digestion analysis and sequencing results demonstrated that no other sequences were introduced into 45S BAC or 45S.R BAC. We then individually transfected WT BAC, 45S BAC, or 45S.R BAC into 293T cells. At 90 h posttransfection, cells transfected with WT BAC and 45S.R showed a severe cytopathic effect (CPE), whereas no CPE was detected in cells transfected with 45S BAC. Two more rounds of passage of the supernatants harvested from 45S BACtransfected cultures onto fresh cells did not result in development of a CPE, indicating that no infectious virus was produced and released into the supernatant (data not shown). Therefore, ORF45 is required for production of extracellular infectivity.
To identify the step of viral lytic replication in which newly synthesized ORF45 may function under BAC transfection conditions, we first attempted to identify a near-single-round viral replication time point through immunofluorescence assay (IFA). Two structural proteins, ORF65 and ORF33, were stained at different time points and examined. At 26 h posttransfection, fluorescence signals for ORF65 ( Fig. 2A, left) or ORF33 (data not shown) in all transfections were in isolated fashion, suggesting no apparent virus spreading from cell to cell at this time point. At 36 h posttransfection, in cells transfected with WT BAC, 45S.R BAC, or 45S BAC plus pFlag45, a large agglomerate of ORF65 ( Fig. 2A, right) or ORF33 (data not shown) fluorescence signals, indicating progeny virions being released from BAC-transfected cells and then infecting neighboring cells, was detected. However, the fluorescence signals were still in isolated fashion in 45S BAC-transfected cells, again confirming that ORF45 was required for completion of viral lytic replication. We then examined the expression of a panel of viral late genes at 26 h posttransfection (i.e., within singleround viral replication). As expected, ORF45 was not expressed in 45S BAC-transfected cells. However, there was no apparent decrease in the expression levels of capsid protein ORF65, tegument proteins ORF33 and ORF38, or ORF67 and ORF69 proteins (homologues of the nuclear egress complex in MHV-68), compared to those of WT BAC-or 45S.R BAC-transfected cells (Fig. 2B) . Densitometric analysis confirmed that the absence of ORF45 did not affect the expression levels of these viral late genes (Fig. 2B) . Expression of these late genes was also successfully detected in 45S BAC-transfected BHK-21 cells, although at lower levels than those in 293T cells (data not shown). These data indicated that the absence of newly synthesized ORF45 did not affect the expression of viral late genes within single-round replication.
The above-described findings, that newly synthesized ORF45 does not affect viral late gene expression but is required for production of progeny virions, suggested that, at later time points, when multiple rounds of viral replication have occurred, the absence of ORF45 would have an effect on viral gene expression. Indeed, at 90 h posttransfection in 293T cells, a panel of viral late genes was successfully detected. However, the expression levels of these genes were significantly lower in 45S BAC-transfected 293T cells than in cells transfected with WT BAC or 45S.R BAC (Fig.  2C ). These data are slightly different from the previous report (Fig. 4B in reference 3) , which may be caused by lower transfection efficiencies in BHK-21 cells as well as inclusion of later time points (5 days posttransfection, i.e., after more rounds of viral replication, which would further amplify the differences in viral gene expression levels due to the absence of ORF45) in that study.
We next examined whether newly synthesized ORF45 may play a role in viral immediate-early or early gene expression. Cotransfection of pGLRp6 (RTA promoter-driven luciferase reporter) or pORF57pLUC (ORF57 promoter-driven luciferase reporter) with MHV-68 BAC (WT, 45S, or 45S.R) and pRenilla-TK (as an internal control) showed that the absence of ORF45 did not affect the activation of either viral promoter, suggesting that ORF45 is not required for expression of viral immediate-early or early genes at the transcription level (Fig. 2D) . Taken together, our results demonstrated that newly synthesized ORF45 protein is not required for expression of viral genes but is required for viral lytic replication under BAC transfection conditions. They also suggested that ORF45 likely plays functional roles in the very late stage of viral lytic replication, i.e., virion assembly and egress.
To determine the role of ORF45 in virion morphogenesis, we examined the ultrastructure of cells transfected with WT BAC, 45S BAC, or 45S.R BAC by thin-section transmission electron microscopy (TEM) at 26 h posttransfection (i.e., within single-round viral replication). Virion assembly and egress were examined by noting the existence of nascent viral particles at each stage of virion maturation, according to the envelopment/deenvelopment/ reenvelopment model. As expected, virion morphogenesis took place normally in WT BAC-or 45S.R BAC-transfected cells, with formation and release of mature virions (Fig. 3, A1 to A3 and C1 to C3, black arrows). In 45S BAC-transfected cells, empty or A capsids, B capsids containing scaffold proteins, and C capsids filled with viral DNAs were visible (Fig. 3, B1 ), indicating that capsid formation was not affected in the absence of ORF45. However, only a small number of capsids (Fig. 3, B2 , black triangles) and no fully enveloped virions were detected in the cytoplasm. Consequently, no mature virions were found at the cell surface (Fig. 3,  B3 ). These data demonstrated that ORF45 is required for virion maturation in the cytoplasm. To quantify the block in virion assembly that occurs in the absence of ORF45, viral particles at various stages of maturation in electron micrographs (as shown in Fig. 3 ) were classified and enumerated. In 45S BAC-transfected cells, the proportion of nuclear capsids to total viral particles (96.15%) is much higher than that in WT BAC (57.10%)-or 45S.R BAC (55.84%)-transfected cells, whereas the proportion of cytoplasmic virions to total viral particles (3.85%) is remarkably lower than that in WT BAC (41.90%)-or 45S.R BAC (43.58%)-transfected cells (Table 1) . These results demonstrated that, in the absence of ORF45, nuclear egress of capsids was markedly inhibited and maturation of virions was finally blocked in the cytoplasm.
In summary, we demonstrated that MHV-68 ORF45 is localized in both the nucleus and the cytoplasm during viral infection, plays functional roles in nuclear egress and cytoplasmic maturation of capsids, and is essential for MHV-68 morphogenesis. Therefore, the ORF45 protein plays dual roles in MHV-68 lytic infection: the virion-associated ORF45 protein plays a critical role in the immediate-early phase of viral replication during de novo infection (3), whereas the newly synthesized ORF45 protein plays an essential role in virion morphogenesis and egress (this study). The detailed mechanisms mediating ORF45's involvement in virion assembly and egress remain to be investigated.
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